Pichia anomala fungaemia in immunocompromised children

M. Bakir, N. Çerikcioǧlu, A. Tirtir, S. Berrak, E. Ösek, C. Canpolat

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Pichia anomala is an emerging yeast causing serious nosocomial infections in newborn and immunocompromised children. We describe nosocomial port catheter infection due to P, anomala in three children who were receiving cancer chemotherapy, bloodstream infection in a preterm infant and in an infant with severe combined immunodeficiency. All patients were treated with amphotericin B. All isolates were susceptible to amphotericin B and fluconazole. No recurrence was observed during follow-up in four of five patients. The common clinical feature in all of our patients was the presence of prior antimicrobial therapy.

Original languageEnglish (US)
Pages (from-to)231-235
Number of pages5
JournalMycoses
Volume47
Issue number5-6
DOIs
StatePublished - Jul 22 2004

Keywords

  • Amphotericin B
  • Children
  • Fungaemia
  • Immunosuppression
  • Nosocomial
  • Pichia anomala

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Pichia anomala fungaemia in immunocompromised children'. Together they form a unique fingerprint.

  • Cite this

    Bakir, M., Çerikcioǧlu, N., Tirtir, A., Berrak, S., Ösek, E., & Canpolat, C. (2004). Pichia anomala fungaemia in immunocompromised children. Mycoses, 47(5-6), 231-235. https://doi.org/10.1111/j.1439-0507.2004.00962.x